{"id":"NCT00661713","sponsor":"Novartis Vaccines","briefTitle":"Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules","officialTitle":"A Phase 2b/3, Multi-Center, Observer-Blind, Controlled Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents Aged 11-17 Years According to Different Vaccination Schedules","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-06","primaryCompletion":"2010-04","completion":"2010-12","firstPosted":"2008-04-18","resultsPosted":"2015-11-04","lastUpdate":"2019-03-20"},"enrollment":1631,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"rMenB+OMV NZ","otherNames":["Serogroup B Meningococcal Vaccine"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"rMenB06","type":"EXPERIMENTAL"},{"label":"rMenB0","type":"EXPERIMENTAL"},{"label":"rMenB016","type":"EXPERIMENTAL"},{"label":"rMenB01","type":"EXPERIMENTAL"},{"label":"rMenB026","type":"EXPERIMENTAL"},{"label":"rMenB02","type":"EXPERIMENTAL"},{"label":"rMenB012","type":"EXPERIMENTAL"},{"label":"rMenB6","type":"EXPERIMENTAL"}],"summary":"The proposed study is aimed to assess the antibody response and short-term persistence of Novartis Meningococcal B Vaccine after one, two or three doses and to evaluate the optimal vaccination schedule in an adolescent population.","primaryOutcome":{"measure":"Percentages of Subjects With hSBA Titer â‰¥1:4 After Receiving One, Two or Three Doses of rMenB+OMV NZ Vaccine.","timeFrame":"Month-1, 2, 3","effectByArm":[{"arm":"rMenB06","deltaMin":42,"sd":null},{"arm":"rMenB0","deltaMin":47,"sd":null},{"arm":"rMenB016","deltaMin":41,"sd":null},{"arm":"rMenB01","deltaMin":38,"sd":null},{"arm":"rMenB026","deltaMin":37,"sd":null},{"arm":"rMenB02","deltaMin":47,"sd":null},{"arm":"rMenB012","deltaMin":46,"sd":null},{"arm":"rMenB6","deltaMin":46,"sd":null}],"pValues":[]},"eligibility":{"minAge":"11 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["Chile"]},"refs":{"pmids":["33020485","22260988"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":128},"commonTop":["INJECTION SITE PAIN","INJECTION SITE ERYTHEMA","MALAISE","MYALGIA","HEADACHE"]}}